Indegene Future Growth
Future criteria checks 2/6
Indegene is forecast to grow revenue at 10.8% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Life Sciences earnings growth | 22.2% |
Revenue growth rate | 10.8% |
Future return on equity | 25.1% |
Analyst coverage | Low |
Last updated | 03 Jul 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2026 | 32,146 | N/A | N/A | N/A | 1 |
3/31/2025 | 28,590 | N/A | N/A | N/A | 1 |
3/31/2024 | 25,896 | 3,367 | 4,970 | 5,077 | N/A |
12/31/2023 | 25,489 | 2,907 | 3,871 | 4,100 | N/A |
3/31/2023 | 23,061 | 2,661 | 1,114 | 1,302 | N/A |
3/31/2022 | 16,646 | 1,648 | 2,723 | 2,970 | N/A |
3/31/2021 | 9,806 | 1,857 | 1,514 | 1,720 | N/A |
3/31/2020 | 6,436 | 558 | 162 | 223 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 544172's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if 544172's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if 544172's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 544172's revenue (10.8% per year) is forecast to grow faster than the Indian market (9.7% per year).
High Growth Revenue: 544172's revenue (10.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 544172's Return on Equity is forecast to be high in 3 years time (25.1%)